| 2 | Associations between polymorphisms in leptin and leptin receptor genes and colorectal cancer survival显示文摘Objective:Leptin(LEP)is an obesity-associated adipokine associated with tumor cell growth.We examined the relevance of genetic variants of LEP and leptin receptor(LEPR)to colorectal cancer(CRC)survival by using data from the Newfoundland Familial Colorectal Cancer Study.Methods:A total of 532 patients newly diagnosed with CRC between 1997 and 2003 were followed up until April 2010.Data on their demographics and lifestyles were collected via questionnaires.Genotyping of blood samples was performed with the Illumina Human Omni-Quad Bead chip.Multivariable Cox models were used to assess the relationships of 35 tag single-nucleotide polymorphisms(SNPs)in LEP and LEPR with overall survival(OS),disease-free survival(DFS),and CRC-specific survival.Results:At the gene level,LEP was associated with DFS(P=0.017),and LEPR was associated with both DFS(P=0.021)and CRCspecific survival(P=0.013)in patients with CRC.In single-SNP analysis,LEP rs11763517,LEPR rs9436301,and LEPR rs7602 were associated with DFS after adjustment for multiple testing.The LEPR haplotypes G-C-T(rs7534511-rs9436301-rs1887285)and A-A-G(rs7602-rs970467-rs9436748)were associated with prolonged OS among patients with CRC overall(G-C-T:HR,0.63;95%CI,0.43–0.93;A-A-G:HR,0.59;95%CI,0.38–0.91)and those diagnosed with colon cancer(G-C-T:HR,0.54;95%CI,0.34–0.86;A-A-G:HR,0.49;95%CI,0.29–0.83).Similar results were observed for DFS.Moreover,significant interactions were found among LEPR rs7602(A vs.G),LEPR rs1171278(T vs.C),red meat intake,and BMI status:the associations between these variants and prolonged DFS were limited to patients with below-median red meat consumption and body mass index(BMI)<25 kg/m2.Conclusions:Polymorphic variations in the LEP and LEPR genes were associated with survival of patients after CRC diagnosis.The LEP/LEPR-CRC survival association was modified by participants’red meat intake and BMI. | Meizhi Du Yu Wang Jillian Vallis Matin Shariati Patrick S.Parfrey John R.Mclaughlin Peizhong Peter Wang Yun Zhu | 2023 | Cancer Biology & Medicine2023，20，6： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员